JPS5578001A - Polysaccharide-polypeptide combination having beta(1-3), (1-6) glucan structure and its preparation - Google Patents

Polysaccharide-polypeptide combination having beta(1-3), (1-6) glucan structure and its preparation

Info

Publication number
JPS5578001A
JPS5578001A JP15127578A JP15127578A JPS5578001A JP S5578001 A JPS5578001 A JP S5578001A JP 15127578 A JP15127578 A JP 15127578A JP 15127578 A JP15127578 A JP 15127578A JP S5578001 A JPS5578001 A JP S5578001A
Authority
JP
Japan
Prior art keywords
polysaccharide
polypeptide
reacted
reaction product
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP15127578A
Other languages
Japanese (ja)
Inventor
Hitoshi Ito
Hiroyoshi Hidaka
Mamoru Sugiura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP15127578A priority Critical patent/JPS5578001A/en
Publication of JPS5578001A publication Critical patent/JPS5578001A/en
Pending legal-status Critical Current

Links

Landscapes

  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

PURPOSE: To obtain the title novel compound useful as oral antitumor, liver function improving, antidepressive, and antihyperlipemia drugs, by reacting the reaction product between a specific polysaccharide and a cyanogen halide with a polypeptide.
CONSTITUTION: The hydroxyl group in the side chain or cleaved terminal glucose ring of the (1-6) bond in (A) a polysaccharide, D-11 of the formula I or its derivative, obtained from mycelia is reacted with (B) a cyanogen halide or perhalogenate. (C) A polypeptide having terminal amino groups, e.g. bovine serum albumin, is reacted with the reaction product thus obtained to give the objective compound. The component (A) is preferably prepared by extracting and purifying a cultured mycelia of Ceriolus Versicolor IWADE.
COPYRIGHT: (C)1980,JPO&Japio
JP15127578A 1978-12-06 1978-12-06 Polysaccharide-polypeptide combination having beta(1-3), (1-6) glucan structure and its preparation Pending JPS5578001A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP15127578A JPS5578001A (en) 1978-12-06 1978-12-06 Polysaccharide-polypeptide combination having beta(1-3), (1-6) glucan structure and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15127578A JPS5578001A (en) 1978-12-06 1978-12-06 Polysaccharide-polypeptide combination having beta(1-3), (1-6) glucan structure and its preparation

Publications (1)

Publication Number Publication Date
JPS5578001A true JPS5578001A (en) 1980-06-12

Family

ID=15515107

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15127578A Pending JPS5578001A (en) 1978-12-06 1978-12-06 Polysaccharide-polypeptide combination having beta(1-3), (1-6) glucan structure and its preparation

Country Status (1)

Country Link
JP (1) JPS5578001A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2314850A (en) * 1995-03-13 1998-01-14 Norvet Research Pty Ltd Process for glucan preparation and therapeutic uses of glucan
KR100563616B1 (en) * 2004-05-20 2006-03-22 그린텍이십일 주식회사 ?-Glucan derivative, manufacture of the derivative, adhesion Barrier using ?-glucan and method thereof
CN106323895A (en) * 2016-08-22 2017-01-11 宁波希诺亚海洋生物科技有限公司 Structural analysis method of beta-glucan

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2314850A (en) * 1995-03-13 1998-01-14 Norvet Research Pty Ltd Process for glucan preparation and therapeutic uses of glucan
GB2314850B (en) * 1995-03-13 1999-07-14 Norvet Research Pty Ltd Process for glucan preparation
US7622575B2 (en) 1995-03-13 2009-11-24 Novogen Research Pty. Ltd. Therapeutic uses of glucan
US7648968B2 (en) 1995-03-13 2010-01-19 Novogen Research Pty. Ltd. Methods of treating dermal ulcers using glucans
US7776843B2 (en) 1995-03-13 2010-08-17 Novogen Research Pty. Ltd. Therapeutic uses of glucan
KR100563616B1 (en) * 2004-05-20 2006-03-22 그린텍이십일 주식회사 ?-Glucan derivative, manufacture of the derivative, adhesion Barrier using ?-glucan and method thereof
CN106323895A (en) * 2016-08-22 2017-01-11 宁波希诺亚海洋生物科技有限公司 Structural analysis method of beta-glucan

Similar Documents

Publication Publication Date Title
IL86809A (en) Second generation monoclonal antibodies with binding specificity to tag-72, method for detecting human carcinomas utilizing the same, and pharmaceutical compositions containing the same
ES8405640A1 (en) Process for preparing free-flowing ethylcellulose microcapsules.
ATE75941T1 (en) POWDERY HYDROPHILIC THEOPHYLLINE FORMULATION AND PROCESS FOR PRODUCTION.
FR2428050A1 (en) OLIGOMERS OF MURAMYL-PEPTIDE COMPOUNDS AND DRUGS CONTAINING THEM
JPS6475484A (en) 4-aminopyridine derivative and acid addition salt thereof
EP1013667A3 (en) Process for preparation of cytokine using a sendai virus expression system
JPS5578001A (en) Polysaccharide-polypeptide combination having beta(1-3), (1-6) glucan structure and its preparation
EP0642507A4 (en) Catalytic antibodies against cocaine and methods of using and producing same.
MY106864A (en) Improved process for cyclic amino acid anticonvulsant compounds.
GB1513185A (en) Immobilized glycoenzymes
DE3162131D1 (en) Process for the preparation of phospho-hydroxy-acetonitrile
ATE25849T1 (en) TRICYCLOPHOSPHAZEN DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS.
ES2052803T3 (en) LIQUID ALLERGENIC COMPOSITION, PHYSIOLOGICALLY ACTIVE OBTAINED FROM BIOLOGICAL RAW MATERIALS AND THE CORRESPONDING PREPARATION PROCESS.
JPS5799598A (en) Hapten antigen and its synthetic intermediate
GB1461688A (en) Pharmaceutical compositions comprising an enzyme and substrate
JPS57192340A (en) Isoprenylamine derivative
IL131513A0 (en) Method for producing 1,3-di-substituted 2-nitroguanidines
JPS5559A (en) Preparation of immobilized bio-active substance
JPS5275580A (en) Process for the preparation of feed
DE3260782D1 (en) Method for the preparation of 1,1'-diacetals
IE830604L (en) Pentanedioic acid derivative
DE3375477D1 (en) Production of formaldehyde
JPS56144095A (en) Preparation of oligoribonucleotide
SU1052513A1 (en) Process for preparing organosiloxanes
EP0241115A3 (en) Process for producing unsaturated phosphonic acid dichlorides